当前位置: X-MOL 学术J. Biomater. Appl. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Tantalum-containing mesoporous bioactive glass powder for hemostasis
Journal of Biomaterials Applications ( IF 2.9 ) Pub Date : 2020-10-15 , DOI: 10.1177/0885328220965150
Malvika Nagrath 1, 2 , Reid Gallant 2, 3 , Alireza Rahimnejad Yazdi 2, 4 , Andrew Mendonca 1, 2 , Saidur Rahman 2, 4 , Loraine Chiu 1, 2 , Stephen D Waldman 1, 2, 5 , Heyu Ni 3, 3, 6 , Mark R Towler 2, 4
Affiliation  

This study evaluates the hemostatic properties of tantalum-containing mesoporous bioactive glasses (Ta-MBGs) through a suite of in-vitro methods: hemolysis percentage, zeta potential, blood coagulation assays (Activated Partial Thromboplastin Time – APTT and Prothrombin Time - PT) and cytotoxicity tests. Five compositions of Ta-MBG, with x mol% Ta2O5 added to the glass series (80-x)SiO2-15CaO-5P2O5-xTa2O5 where x=0 (0Ta), x=0.5 (0.5Ta), x=1 (1Ta), x=5 (5Ta), and x=10 (10Ta) mol%, were synthesised. The hemostatic potential of all the Ta-MBGs was confirmed by their negative zeta potential (–23 to –31 mV), which enhances the intrinsic pathway of blood coagulation. The hemolysis percentages of all Ta-MBGs except 10Ta showed statistically significant reductions compared to the same experiments carried out both in the absence of a sample (‘no treatment’ group) and in the presence of 10Ta. These observations validate the consideration of Ta-MBGs as hemostatic agents as they do not cause significant lysis of red blood cells. Cytotoxicity analysis revealed that Ta-MBGs had no effect on bovine fibroblast viability. Furthermore, a reduction in both APTT (a test to evaluate the intrinsic pathway of coagulation) and PT (a test to evaluate the extrinsic pathway) signified enhancement of hemostasis: 5Ta caused a significant reduction in APTT compared to ‘no treatment’, 1Ta and 10Ta and a significant reduction in PT compared to 0Ta. Therefore, we conclude that 5mol% of Ta optimised the hemostatic properties of these mesoporous bioactive glasses.



中文翻译:

用于止血的含钽介孔生物活性玻璃粉

本研究通过一系列体外方法评估含钽介孔生物活性玻璃 (Ta-MBG) 的止血特性:溶血百分比、zeta 电位、凝血测定(活化部分凝血活酶时间 - APTT 和凝血酶原时间 - PT)和细胞毒性试验。Ta-MBG 的五种成分,其中x mol% Ta 2 O 5添加到玻璃系列 (80- x )SiO 2 -15CaO-5P 2 O 5 - x Ta 2 O 5其中x =0 (0Ta), x = 0.5 (0.5Ta), x =1 (1Ta), x=5 (5Ta),且x=10 (10Ta) mol%,合成。所有 Ta-MBG 的止血电位均由其负 zeta 电位(–23 至–31 mV)证实,这增强了血液凝固的内在途径。与在没有样品(“未处理”组)和存在 10Ta 的情况下进行的相同实验相比,除 10Ta 之外的所有 Ta-MBG 的溶血百分比显示出统计学上显着的降低。这些观察结果验证了将 Ta-MBG 作为止血剂的考虑,因为它们不会导致红细胞显着溶解。细胞毒性分析表明,Ta-MBGs 对牛成纤维细胞的活力没有影响。此外,APTT(评估凝血内在途径的测试)和 PT(评估外在途径的测试)的减少表明止血的增强:与“未处理”、1Ta 和 10Ta 相比,5Ta 导致 APTT 显着降低,与 0Ta 相比,PT 显着降低。因此,我们得出结论,5mol% 的 Ta 优化了这些介孔生物活性玻璃的止血性能。

更新日期:2020-10-17
down
wechat
bug